Literature DB >> 30116074

Fast-tracking of new drugs: getting the balance right.

Paul Kubler1.   

Abstract

Keywords:  drug regulation; product approval

Year:  2018        PMID: 30116074      PMCID: PMC6091770          DOI: 10.18773/austprescr.2018.032

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  3 in total

1.  The hazards of rapid approval of new drugs.

Authors:  Jennifer Martin; Gillian Shenfield
Journal:  Aust Prescr       Date:  2016-02-01

Review 2.  Dealing with the spiralling price of medicines: issues and solutions.

Authors:  Chun K K Ma; Mark Danta; Richard Day; David D F Ma
Journal:  Intern Med J       Date:  2018-01       Impact factor: 2.048

3.  Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.

Authors:  Courtney Davis; Huseyin Naci; Evrim Gurpinar; Elita Poplavska; Ashlyn Pinto; Ajay Aggarwal
Journal:  BMJ       Date:  2017-10-04
  3 in total
  3 in total

1.  Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?

Authors:  Ian D Coombes; Amy Legg; Tina Patterson; Tanya Kelly; Andrew Henderson; Jason A Roberts
Journal:  Aust Prescr       Date:  2022-03-24

2.  Fast-track pathways for drug approvals: the Australian experience so far.

Authors:  Adrian Bootes; Josephine Maundu; Sarah Golding; Mark McDonald; John Lombard
Journal:  Aust Prescr       Date:  2019-08-01

3.  [Regulations on expanded access and compassionate use of medicines in South AmericaRegulación de los programas de acceso ampliado y uso compasivo de medicamentos en América del Sur].

Authors:  Gabriela Bittencourt Gonzalez Mosegui; Fernando Antoñanzas
Journal:  Rev Panam Salud Publica       Date:  2019-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.